|
Company Profile for
Nutri Pharmaceuticals Research, Inc.
Friday September 21, 10:40 am ET
--(BUSINESS WIRE)--Nutri Pharmaceuticals Research, Inc.
provides a wide range of powdered oils for functional
food, food supplement; pharmaceutical; cosmetic; pet
food and animal feed applications. The company is one of
a select few to be awarded the prestigious Nutrition
Business Journal "Product Merit Award" for its
patent-pending O2P(TM) Powderization process. The
O2P(TM) Oil-to-Powder technology is a process that
converts most edible oils, gels or pastes into a
free-flowing powder without affecting the isomeric
structure, fatty acid profile, color, taste or aroma of
the base oil. O2P(TM) does not rely on traditional
techniques that utilize extremes in heat or cold,
micro-encapsulation or nano technology. This facilitates
food marketing and supplement producers' ability to
create functional foods and nutraceuticals by adding
anti-oxidants, specific EFAs, or other fatty acids such
as EPA, GLA, DHA, and CLA to assist in maintaining
specific health issues. The company currently offers
more than 50 shelf-stable powders. The company can also
apply O2P(TM) technology to a third-party's oil, paste
or gel through an arrangement called tolling.
Company: Nutri
Pharmaceuticals Research, Inc.
Headquarters Address: 6780 Caballo Street
Las Vegas, NV 89119
Main Telephone: 702-309-8627
Website: www.o2pus.com
Ticker: NRPR(PINK SHEETS)
Type of Organization: Public IRPR
Industry: Biotechnology
Key Executives: CEO: Godfrey Yew
Director I.R.: Fabio Sunago
Investor Relations
Contact: Fabio Sunago
Phone: 702-309-8627
Investor Relations
Contact: Mike King
Phone: 702-650-3000
--------------------------------------------------------------------------------
Source: Nutri Pharmaceuticals Research, Inc.
Click here to get News Releases
NPRI Reports
Record First Quarter Earnings
|